ArticlePloS one2024

Pre-existing autoimmune disease as a risk factor for immune-related adverse events in cancer patients receiving immune checkpoint inhibitors.

Hidetoshi Sumimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.